First Time Loading...

Arbutus Biopharma Corp
NASDAQ:ABUS

Watchlist Manager
Arbutus Biopharma Corp Logo
Arbutus Biopharma Corp
NASDAQ:ABUS
Watchlist
Price: 3.16 USD -2.77% Market Closed
Updated: Jun 14, 2024
Have any thoughts about
Arbutus Biopharma Corp?
Write Note

Arbutus Biopharma Corp
Other Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Arbutus Biopharma Corp
Other Current Liabilities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Other Current Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Other Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Arbutus Biopharma Corp
NASDAQ:ABUS
Other Current Liabilities
$11.5m
CAGR 3-Years
286%
CAGR 5-Years
96%
CAGR 10-Years
-5%
Abbvie Inc
NYSE:ABBV
Other Current Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Other Current Liabilities
$3.3B
CAGR 3-Years
149%
CAGR 5-Years
406%
CAGR 10-Years
26%
Amgen Inc
NASDAQ:AMGN
Other Current Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Other Current Liabilities
$648.6m
CAGR 3-Years
32%
CAGR 5-Years
8%
CAGR 10-Years
27%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Other Current Liabilities
$516.7m
CAGR 3-Years
4%
CAGR 5-Years
-1%
CAGR 10-Years
23%

See Also

What is Arbutus Biopharma Corp's Other Current Liabilities?
Other Current Liabilities
11.5m USD

Based on the financial report for Mar 31, 2024, Arbutus Biopharma Corp's Other Current Liabilities amounts to 11.5m USD.

What is Arbutus Biopharma Corp's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 10Y
-5%

Over the last year, the Other Current Liabilities growth was -24%. The average annual Other Current Liabilities growth rates for Arbutus Biopharma Corp have been 286% over the past three years , 96% over the past five years , and -5% over the past ten years .